Schioppa, Tiziana
 Distribuzione geografica
Continente #
AS - Asia 35
EU - Europa 20
NA - Nord America 10
Totale 65
Nazione #
HK - Hong Kong 16
SG - Singapore 15
MX - Messico 6
DE - Germania 5
GB - Regno Unito 5
CN - Cina 4
FR - Francia 4
IT - Italia 4
US - Stati Uniti d'America 4
PL - Polonia 2
Totale 65
Città #
Hong Kong 16
Singapore 15
Mexico City 6
Frankfurt am Main 5
Beijing 4
Bexley 3
Ashburn 2
London 2
Palermo 2
Santa Clara 2
Wroclaw 2
Brescia 1
Rome 1
Totale 61
Nome #
CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer 12
Urethane-induced lung carcinogenesis 4
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis 4
Chemerin in immunity 4
Author Correction: Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis 4
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation) 4
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer 4
p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance 4
Role of tumor-associated macrophages in tumor progression and invasion 3
TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses 3
Regulation of the Chemokine Receptor CXCR4 by Hypoxia 3
Bartonella henselae persistence within Mesenchymal stromal cells enhances endothelial cell activation and infectibility that amplifies the angiogenic process 3
Divergent effects of hypoxia on dendritic cell functions 3
Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells 3
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy 3
The chemokine system: Tuning and shaping by regulation of receptor expression and coupling in polarized responses 3
Leukocyte trafficking in tumor microenvironment 3
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis 3
Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations 3
Extracellular vesicles at the crossroad between cancer progression and immunotherapy: focus on dendritic cells 2
The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity 2
The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance 2
Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth 2
Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7/8 engagement 2
Chemokine and chemotactic signals in dendritic cell migration review-article 2
Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer 2
Inhibition of Class I Histone Deacetylase Activity Blocks the Induction of TNFAIP3 Both Directly and Indirectly via the Suppression of Endogenous TNF-α 2
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment 2
Functional role of dendritic cell subsets in cancer progression and clinical implications 2
Interleukin-6 as a therapeutic target in human ovarian cancer 2
SARS-CoV-2–associated ssRNAs activate inflammation and immunity via TLR7/8 1
Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity 1
Molecular Basis for CCRL2 Regulation of Leukocyte Migration 1
The PDE4 Inhibitor Tanimilast Restrains the Tissue‐Damaging Properties of Human Neutrophils 1
The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation 1
The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs 1
Totale 101
Categoria #
all - tutte 395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026101 101 0 0 0 0 0 0 0 0 0 0 0
Totale 101